VanEck Genomics and Healthcare Innovators UCITS ETF
CURE.DE
#3264
ETF rank
โ‚ฌ11.96 M
Marketcap
๐Ÿ‡ช๐Ÿ‡บ EU
Market
19,61ย โ‚ฌ
Share price
1.23%
Change (1 day)
10.30%
Change (1 year)

Expense ratio and fees for VanEck Genomics and Healthcare Innovators UCITS ETF (CURE.DE)

Total Expense Ratio

Total Expense Ratio as of July 2026: 0.35%